His6-TEV-CRBN-midi Citations (3)
Originally described in: Design of a Cereblon construct for crystallographic and biophysical studies of protein degraders.Kroupova A, Spiteri VA, Rutter ZJ, Furihata H, Darren D, Ramachandran S, Chakraborti S, Haubrich K, Pethe J, Gonzales D, Wijaya AJ, Rodriguez-Rios M, Sturbaut M, Lynch DM, Farnaby W, Nakasone MA, Zollman D, Ciulli A Nat Commun. 2024 Oct 15;15(1):8885. doi: 10.1038/s41467-024-52871-9. PubMed Journal
Articles Citing His6-TEV-CRBN-midi
| Articles |
|---|
Characterization of PROTAC specificity and endogenous protein interactomes using ProtacID.
Shrestha S, Maitland MER, Jing L, Duan S, Nie DY, St-Germain J, Kanaris M, Barsyte-Lovejoy D, Arrowsmith CH, Raught B.
Nat Commun. 2025 Aug 29;16(1):8089. doi: 10.1038/s41467-025-63357-7.
PubMed
Associated Plasmids |
| PROTAC repurposing uncovers a noncanonical binding surface that mediates chemical degradation of nuclear receptors. Huber AD, Lin W, Jung YH, Poudel S, Yang G, Wu J, Carrigan AG, Pagala V, Wang W, Fu Y, Yuan ZF, Byrum SD, Yang K, Gee RRF, Arnold ED, Loughran AJ, Wang J, Pruett-Miller SM, Peng J, Chen T. Nat Commun. 2025 Nov 6;16(1):9805. doi: 10.1038/s41467-025-64773-5. PubMed |
| High-throughput ligand diversification to discover chemical inducers of proximity. Shaum JB, Munoz I Ordono M, Steen EA, Wenge DV, Cheong H, Janowski J, Hunkeler M, Bilotta EM, Rutter ZJ, Barta PA, Thornhill AM, Milosevich N, Hargis LM, Bishop TR, Carter TR, da Camara B, Hinterndorfer M, Dada L, He WJ, Offensperger F, Furihata H, Schweber SR, Hatton C, Wen Y, Cravatt BF, Engle KM, Donovan KA, Melillo B, Kitamura S, Ciulli A, Armstrong SA, Fischer ES, Winter GE, Erb MA. Nat Chem Biol. 2026 Feb 16. doi: 10.1038/s41589-025-02137-2. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.